About: Marie-Camille Chaumais

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Marie-Camille Chaumais Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) wetenschapper (nl) дослідниця (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy)
rdfs:label	Marie-Camille Chaumais (en) Marie-Camille Chaumais (es) Marie-Camille Chaumais (nl) Marie-Camille Chaumais (ast)
skos:prefLabel	Marie-Camille Chaumais (en) Marie-Camille Chaumais (es) Marie-Camille Chaumais (nl) Marie-Camille Chaumais (ast)
name	Marie-Camille Chaumais (en) Marie-Camille Chaumais (es) Marie-Camille Chaumais (nl) Marie-Camille Chaumais (ast)
instance of	wds:Q57089654-804B43CC-8EDA-41CB-901D-43594F386AED
instance of	Homo sapiens
doctoral advisor	wds:Q57089654-EB524B8D-CB44-4DB1-93A1-32AD739B2760
doctoral advisor	Marc Humbert
occupation	wds:Q57089654-4221C2F2-4379-4A99-99A1-2F251F57A7A7
employer	wds:Q57089654-C3CA28F7-3612-447D-B182-43A33EC37766
sex or gender	wds:Q57089654-11D4D62D-374E-42DB-AB23-739160B59155
ISNI	wds:Q57089654-6E9E3F6D-CDCA-439A-AA50-E8A3A703D3DB
VIAF ID	wds:Q57089654-7A578D83-3B97-4E94-97D6-B8DBD5588E21
IdRef ID	wds:Q57089654-36E5322E-509C-41D9-98D6-786CB854E277
date of birth	wds:Q57089654-AF367F23-E07A-4228-9649-73A029FE1B26
educated at	wds:Q57089654-7DD5B6E6-6BB5-4C01-BCE2-3A1016B53632 wds:Q57089654-8402F61E-7D04-44E8-A656-895AD64E3DEE
VIAF ID	http://viaf.org/viaf/285383826
IdRef ID	http://www.idref.fr/161193447/id
occupation	researcher
employer	Hôpital Antoine-Béclère
sex or gender	female organism
ISNI	0000000391551918
VIAF ID	285383826
IdRef ID	161193447
date of birth	1981-01-01 00:00:00Z (xsd:dateTime)
educated at	University of Paris-Sud
ORCID iD	wds:Q57089654-DE782CBD-BEDB-4692-937D-8725743B8CE5
ORCID iD	https://orcid.org/0000-0002-1217-8442
ORCID iD	0000-0002-1217-8442
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57089654
is author of	N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats Targeted therapies in pulmonary arterial hypertension Chemotherapy-induced pulmonary hypertension: role of alkylating agents. Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models. Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension. New pharmacotherapy options for pulmonary arterial hypertension. Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. Pulmonary arterial hypertension in patients treated with interferon. Pulmonary Complications of Bcr-Abl Tyrosine Kinase Inhibitors Pulmonary arterial hypertension induced by tyrosine kinase inhibitors. Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension. Calcium-channel blockers in pulmonary arterial hypertension. Pharmacokinetic evaluation of continuous intravenous epoprostenol Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitis. Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma Drugs induced pulmonary arterial hypertension Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity. Interferon-induced pulmonary hypertension: an update. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation Pulmonary arterial hypertension in patients treated with interferon Pulmonary hypertension associated with benfluorex exposure [Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication]. Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease. Lorlatinib - Induced pulmonary arterial hypertension. A study of magnesium deficiency in human and experimental pulmonary hypertension Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacae Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study. Nouvelles approches immunopathologiques de l’hypertension artérielle pulmonaire Prevalence of drug-related problems associated with direct oral anticoagulants in hospitalized patients: a multicentre, cross-sectional study Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy. Evaluation of a program of pharmaceutical counseling for French patients on oral anticoagulant therapy Response to Letter Regarding Article, “Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model”
is author of	wds:Q33786092-192BA302-B728-4963-B2C1-2E18902A4611 wds:Q37600767-E9FA30A8-E549-46DE-92D1-B78AB3AB0198 wds:Q38153497-89E6A502-481B-4A01-9944-1038B8D348D5 wds:Q96301072-5888EB12-B51C-4483-A9CD-C48753BF0CB3 wds:Q34508259-1B22D2AF-6C83-45C3-AACE-2C9641B5B80C wds:Q37410202-2C5369ED-66C5-47C4-B725-5D852695418F wds:Q37809538-53B1E94C-0AF8-461D-9053-A1F1B8C0B9DC wds:Q38131111-3F647D21-7DF1-4817-B1D6-66DF6AA02D55 wds:Q51283435-E9E5DFB9-A516-4E9A-85FC-05188D7549C1

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software